Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) [Phase 2]

View source ↗

Summary

A Phase 2 study investigating reduced-intensity pre-transplant conditioning prior to allogeneic hematopoietic stem cell transplantation for high-risk hematologi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Snippet

Sponsor: Medical University of South Carolina | Conditions: Hematological Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2016-03-10